Inj Octreotide Lar 30 Mg,Human Insulin Analogue Glargine Inj 100 Iu Per Ml Recombinant Dna Origin 3 Quantity: 202191

Name: Inj Octreotide Lar 30 Mg,Human Insulin Analogue Glargine Inj 100 Iu Per Ml Recombinant Dna Origin 3 Quantity: 202191
Start: 2025-08-20
End: 2025-08-29
Location: Ministry of Defence Department of Military Affairs

Ministry of Defence Department of Military Affairs India has Released a tender for Inj Octreotide Lar 30 Mg,Human Insulin Analogue Glargine Inj 100 Iu Per Ml Recombinant Dna Origin 3 Quantity: 202191 in Pharmaceuticals. The tender was released on Aug 19, 2025.

Country - India

Summary - Inj Octreotide Lar 30 Mg,Human Insulin Analogue Glargine Inj 100 Iu Per Ml Recombinant Dna Origin 3 Quantity: 202191

Deadline - Aug 29, 2025

MT reference number - 115955471

Product classification - Medicinal products for the alimentary tract and metabolism

Organization Details:

Address - India

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 115955471

Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Inj Octreotide Lar 30 Mg,Human Insulin Analogue Glargine Inj 100 Iu Per Ml Recombinant Dna Origin 3 Quantity: 202191local title:: Inj Octreotide Lar 30 mg,Human Insulin Analogue Glargine Inj 100 Iu per Ml Recombinant Dna Origin 3 Quanti ty: 202191 tender_quantity: 202191

Mt Ref Id - 115955471

Deadline - Aug 29, 2025

View more tenders for

Medicinal products for the ali Tenders India Tenders

Similar Tenders :

Most Searched